Maltriptase-2 is a negative regulator of hepcidin, cleaving HJV on hepatocytes, while the increased maltriptase-2 expression reported in HCC is correlated with downregulation of hepcidin expression or prevention of hepcidin upregulation in HCC [171,172]. This evidence concerns the gene HAMP and hepatocellular carcinoma.